KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Shares Issued (2016 - 2025)

Labcorp Holdings (LH) has disclosed Shares Issued for 17 consecutive years, with $28.6 million as the latest value for Q3 2025.

  • Quarterly Shares Issued rose 8.75% to $28.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $54.3 million through Dec 2025, down 3.38% year-over-year, with the annual reading at $54.3 million for FY2025, 3.38% down from the prior year.
  • Shares Issued hit $28.6 million in Q3 2025 for Labcorp Holdings, up from $25.7 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $31.5 million in Q3 2022 to a low of $900000.0 in Q4 2021.
  • Historically, Shares Issued has averaged $19.1 million across 5 years, with a median of $25.2 million in 2021.
  • Biggest five-year swings in Shares Issued: plummeted 83.02% in 2021 and later surged 2877.78% in 2023.
  • Year by year, Shares Issued stood at $900000.0 in 2021, then soared by 3400.0% to $31.5 million in 2022, then fell by 14.92% to $26.8 million in 2023, then crashed by 88.06% to $3.2 million in 2024, then surged by 793.75% to $28.6 million in 2025.
  • Business Quant data shows Shares Issued for LH at $28.6 million in Q3 2025, $25.7 million in Q1 2025, and $3.2 million in Q4 2024.